Clinical Trial Update: Pre-transplant Immunosuppression and Donor Stem Cell Transplant for the Treatment of Severe Hemoglobinopathies [EARLY_Phase 1]

View source ↗

Summary

The Early Phase 1 trial investigating pre-transplant immunosuppression and donor stem cell transplantation for severe hemoglobinopathies has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Beta Thalassemia Major
• Sickle Cell Disease

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Beta Thalassemia Major, Sickle Beta 0 Thalassemia | EARLY_Phase 1 | Status: WITHDRAWN